Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Marquet

Showing results (31-40 of 390) with videos related to

Pageof 39
Sort By:
Therapeutic Drug Monitoring|July 23, 2025
Estimation of Overall Cyclosporine Exposure Using Machine LearningJean-Baptiste Woillard, Marc Labriffe, Pierre Marquet
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2005
In vitro metabolism study of buprenorphine: evidence for new metabolic pathwaysNicolas Picard, Thierry Cresteil, Nassim Djebli, et al.
Pharmacogenomics|January 23, 2016
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsLucie Pouché, Jana Stojanova, Pierre Marquet, et al.
Journal of Chromatography. A|April 28, 2012
Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometryFrançois-Ludovic Sauvage, Louis Noël Gastinel, Pierre Marquet
Journal of Cellular and Molecular Medicine|August 2, 2011
Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidneyVirginie Descazeaud, Elodie Mestre, Pierre Marquet, et al.
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|February 24, 2022
Impact of wavefront aberrations on the duration of few-cycle laser pulsesCharles Pichette, Michel Piché, Pierre Marquet, et al.
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of mTOR InhibitorsOlga Millán, Eberhard Wieland, Pierre Marquet, et al.
Pharmacological Research|November 9, 2010
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinantsJana Stojanova, Sophie Caillard, Annick Rousseau, et al.
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|October 10, 2022
Study of the impact of wavefront aberrations on the characterization of ultrashort laser pulses with GRENOUILLECharles Pichette, Michel Piché, Pierre Marquet, et al.
Therapeutic Drug Monitoring|December 1, 2004
Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5Nicolas Picard, Thierry Cresteil, Aurélie Prémaud, et al.
Pageof 39

Showing results (31-40 of 390) with videos related to

Sort By:
Pageof 39
Therapeutic Drug Monitoring|July 23, 2025
Estimation of Overall Cyclosporine Exposure Using Machine LearningJean-Baptiste Woillard, Marc Labriffe, Pierre Marquet
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2005
In vitro metabolism study of buprenorphine: evidence for new metabolic pathwaysNicolas Picard, Thierry Cresteil, Nassim Djebli, et al.
Pharmacogenomics|January 23, 2016
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsLucie Pouché, Jana Stojanova, Pierre Marquet, et al.
Journal of Chromatography. A|April 28, 2012
Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometryFrançois-Ludovic Sauvage, Louis Noël Gastinel, Pierre Marquet
Journal of Cellular and Molecular Medicine|August 2, 2011
Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidneyVirginie Descazeaud, Elodie Mestre, Pierre Marquet, et al.
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|February 24, 2022
Impact of wavefront aberrations on the duration of few-cycle laser pulsesCharles Pichette, Michel Piché, Pierre Marquet, et al.
Therapeutic Drug Monitoring|March 19, 2019
Pharmacodynamic Monitoring of mTOR InhibitorsOlga Millán, Eberhard Wieland, Pierre Marquet, et al.
Pharmacological Research|November 9, 2010
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinantsJana Stojanova, Sophie Caillard, Annick Rousseau, et al.
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|October 10, 2022
Study of the impact of wavefront aberrations on the characterization of ultrashort laser pulses with GRENOUILLECharles Pichette, Michel Piché, Pierre Marquet, et al.
Therapeutic Drug Monitoring|December 1, 2004
Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5Nicolas Picard, Thierry Cresteil, Aurélie Prémaud, et al.
Pageof 39